US3645090A
(en)
|
1969-06-19 |
1972-02-29 |
Citizen Watch Co Ltd |
Day-date quick-adjuster for calender timepiece
|
US3691016A
(en)
|
1970-04-17 |
1972-09-12 |
Monsanto Co |
Process for the preparation of insoluble enzymes
|
US3940475A
(en)
|
1970-06-11 |
1976-02-24 |
Biological Developments, Inc. |
Radioimmune method of assaying quantitatively for a hapten
|
CA1023287A
(en)
|
1972-12-08 |
1977-12-27 |
Boehringer Mannheim G.M.B.H. |
Process for the preparation of carrier-bound proteins
|
US4195128A
(en)
|
1976-05-03 |
1980-03-25 |
Bayer Aktiengesellschaft |
Polymeric carrier bound ligands
|
US4330440A
(en)
|
1977-02-08 |
1982-05-18 |
Development Finance Corporation Of New Zealand |
Activated matrix and method of activation
|
CA1093991A
(en)
|
1977-02-17 |
1981-01-20 |
Hideo Hirohara |
Enzyme immobilization with pullulan gel
|
US4229537A
(en)
|
1978-02-09 |
1980-10-21 |
New York University |
Preparation of trichloro-s-triazine activated supports for coupling ligands
|
US4376110A
(en)
|
1980-08-04 |
1983-03-08 |
Hybritech, Incorporated |
Immunometric assays using monoclonal antibodies
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
DE3422247A1
(de)
|
1984-06-15 |
1985-12-19 |
Pfeifer & Langen, 5000 Köln |
Gluco-oligosaccharid-gemisch und verfahren zu seiner herstellung
|
US4737456A
(en)
|
1985-05-09 |
1988-04-12 |
Syntex (U.S.A.) Inc. |
Reducing interference in ligand-receptor binding assays
|
US5567610A
(en)
|
1986-09-04 |
1996-10-22 |
Bioinvent International Ab |
Method of producing human monoclonal antibodies and kit therefor
|
WO1989004838A1
(en)
|
1987-11-25 |
1989-06-01 |
Immunex Corporation |
Interleukin-1 receptors
|
US5359037A
(en)
|
1988-09-12 |
1994-10-25 |
Yeda Research And Development Co. Ltd. |
Antibodies to TNF binding protein I
|
GB8823869D0
(en)
|
1988-10-12 |
1988-11-16 |
Medical Res Council |
Production of antibodies
|
WO1990005183A1
(en)
|
1988-10-31 |
1990-05-17 |
Immunex Corporation |
Interleukin-4 receptors
|
US5175384A
(en)
|
1988-12-05 |
1992-12-29 |
Genpharm International |
Transgenic mice depleted in mature t-cells and methods for making transgenic mice
|
US5011778A
(en)
|
1989-05-23 |
1991-04-30 |
Otsuka Pharmaceutical Co., Ltd. |
Monoclonal antibodies directed to IL-1 activated endothelial cells and medicaments employing the monoclonal antibodies
|
EP0402226A1
(en)
|
1989-06-06 |
1990-12-12 |
Institut National De La Recherche Agronomique |
Transformation vectors for yeast yarrowia
|
DE3920358A1
(de)
|
1989-06-22 |
1991-01-17 |
Behringwerke Ag |
Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung
|
SK279933B6
(sk)
|
1989-12-20 |
1999-06-11 |
Schering Corporation |
Polypeptid, jeho subsekvencie a ich použitie
|
US5229275A
(en)
|
1990-04-26 |
1993-07-20 |
Akzo N.V. |
In-vitro method for producing antigen-specific human monoclonal antibodies
|
US5571894A
(en)
|
1991-02-05 |
1996-11-05 |
Ciba-Geigy Corporation |
Recombinant antibodies specific for a growth factor receptor
|
CA2083826C
(en)
|
1991-03-29 |
1999-04-27 |
Daniel Caput |
Protein having cytokine type activity, recombinant dna coding for this protein, transformed cells and microorganisms
|
IE922437A1
(en)
|
1991-07-25 |
1993-01-27 |
Idec Pharma Corp |
Recombinant antibodies for human therapy
|
US5994514A
(en)
|
1991-08-14 |
1999-11-30 |
Genentech, Inc. |
Immunoglobulin variants
|
US6329509B1
(en)
|
1991-08-14 |
2001-12-11 |
Genentech, Inc. |
Anti-IgE antibodies
|
US5965709A
(en)
|
1991-08-14 |
1999-10-12 |
Genentech, Inc. |
IgE antagonists
|
ES2136092T3
(es)
|
1991-09-23 |
1999-11-16 |
Medical Res Council |
Procedimientos para la produccion de anticuerpos humanizados.
|
US5587458A
(en)
|
1991-10-07 |
1996-12-24 |
Aronex Pharmaceuticals, Inc. |
Anti-erbB-2 antibodies, combinations thereof, and therapeutic and diagnostic uses thereof
|
EP0617706B1
(en)
|
1991-11-25 |
2001-10-17 |
Enzon, Inc. |
Multivalent antigen-binding proteins
|
DE69334255D1
(de)
|
1992-02-06 |
2009-02-12 |
Novartis Vaccines & Diagnostic |
Marker für Krebs und biosynthetisches Bindeprotein dafür
|
WO1993015766A1
(en)
|
1992-02-10 |
1993-08-19 |
Seragen, Inc. |
Desensitization to specific allergens
|
JP3571337B2
(ja)
|
1992-02-11 |
2004-09-29 |
セル ジェネシス,インコーポレーテッド |
遺伝子標的現象による同型遺伝子接合
|
US5573905A
(en)
|
1992-03-30 |
1996-11-12 |
The Scripps Research Institute |
Encoded combinatorial chemical libraries
|
AU680816B2
(en)
*
|
1992-05-15 |
1997-08-14 |
Quest International B.V. |
Cloning and expression of DNA encoding a ripening form of a polypeptide having phamnogalacturonase activity
|
US5397703A
(en)
|
1992-07-09 |
1995-03-14 |
Cetus Oncology Corporation |
Method for generation of antibodies to cell surface molecules
|
CA2142860A1
(en)
|
1992-08-21 |
1994-03-03 |
Gregorio Aversa |
Human interleukin-13
|
US5596072A
(en)
|
1992-08-21 |
1997-01-21 |
Schering Corporation |
Method of refolding human IL-13
|
DE69329503T2
(de)
|
1992-11-13 |
2001-05-03 |
Idec Pharma Corp |
Therapeutische Verwendung von chimerischen und markierten Antikörpern, die gegen ein Differenzierung-Antigen gerichtet sind, dessen Expression auf menschliche B Lymphozyt beschränkt ist, für die Behandlung von B-Zell-Lymphoma
|
EP0604693A1
(en)
|
1992-12-29 |
1994-07-06 |
Schering-Plough |
Monoclonal antibodies against the human interleukin-4 receptor and hybridomas producing the same
|
WO1994026908A1
(en)
*
|
1993-05-17 |
1994-11-24 |
Genentech, Inc. |
Cho cell sialidase by recombinant dna technology
|
AU696235B2
(en)
|
1993-09-02 |
1998-09-03 |
Bristol-Myers Squibb Company |
Anti-GP39 antibodies and uses therefor
|
EP0659766A1
(en)
|
1993-11-23 |
1995-06-28 |
Schering-Plough |
Human monoclonal antibodies against human cytokines and methods of making and using such antibodies
|
US5429746A
(en)
|
1994-02-22 |
1995-07-04 |
Smith Kline Beecham Corporation |
Antibody purification
|
US5534615A
(en)
|
1994-04-25 |
1996-07-09 |
Genentech, Inc. |
Cardiac hypertrophy factor and uses therefor
|
GB9415379D0
(en)
|
1994-07-29 |
1994-09-21 |
Smithkline Beecham Plc |
Novel compounds
|
US5705154A
(en)
|
1995-03-08 |
1998-01-06 |
Schering Corporation |
Humanized monoclonal antibodies against human interleukin-4
|
US6518061B1
(en)
|
1995-03-15 |
2003-02-11 |
The United States Of America As Represented By The Department Of Health And Human Services |
IL-13 receptor specific chimeric proteins and uses thereof
|
US6037453A
(en)
|
1995-03-15 |
2000-03-14 |
Genentech, Inc. |
Immunoglobulin variants
|
US5641870A
(en)
|
1995-04-20 |
1997-06-24 |
Genentech, Inc. |
Low pH hydrophobic interaction chromatography for antibody purification
|
DE69638050D1
(de)
|
1995-10-23 |
2009-11-19 |
Zenyth Operations Pty Ltd |
Hemopoietin-rezeptor und dafür kodierende genetische sequenzen
|
US6911530B1
(en)
|
1995-10-23 |
2005-06-28 |
Amrad Operations, Pty., Ltd. |
Haemopoietin receptor and genetic sequences encoding same
|
FR2742156A1
(fr)
|
1995-12-06 |
1997-06-13 |
Sanofi Sa |
Polypeptide recepteur de l'il-13
|
CN101712720A
(zh)
|
1996-02-09 |
2010-05-26 |
艾博特生物技术有限公司 |
结合人TNFα的人抗体
|
US6664227B1
(en)
|
1996-03-01 |
2003-12-16 |
Genetics Institute, Llc |
Treatment of fibrosis by antagonism of IL-13 and IL-13 receptor chains
|
US5710023A
(en)
|
1996-03-01 |
1998-01-20 |
Genetics Institute, Inc. |
IL-13 cytokine receptor chain
|
US7078494B1
(en)
|
1996-03-01 |
2006-07-18 |
Genetics Institute, Llc |
Antibodies to human IL-13bc and methods of their use in inhibiting IL-13 binding
|
AU6450196A
(en)
|
1996-06-12 |
1998-01-07 |
Human Genome Sciences, Inc. |
Hr-1 receptor
|
WO1998010638A1
(en)
|
1996-09-10 |
1998-03-19 |
Amrad Operations Pty. Ltd. |
Therapeutic molecules
|
ES2337091T3
(es)
|
1996-11-27 |
2010-04-20 |
Genentech, Inc. |
Purificacion por afinidad de polipeptido en una matriz de proteina.
|
US6743604B1
(en)
|
1996-12-13 |
2004-06-01 |
Smithkline Beecham Corporation |
Substances and their uses
|
GB9625899D0
(en)
|
1996-12-13 |
1997-01-29 |
Glaxo Group Ltd |
Substances and their uses
|
TR200001248T2
(tr)
|
1997-01-10 |
2000-07-21 |
Biogen,Inc. |
Anti-CD40L bileşikleri ile lupus nefritis tedavisi
|
CA2278106C
(en)
|
1997-01-22 |
2005-04-12 |
Board Of Regents, The University Of Texas System |
Tissue factor methods and compositions for coagulation and tumor treatment
|
US6576232B1
(en)
|
1998-04-03 |
2003-06-10 |
The Penn State Research Foundation |
IL13 mutants
|
US6482403B1
(en)
|
1998-05-29 |
2002-11-19 |
Heska Corporation |
Caniney IL-13 immunoregulatory proteins and uses thereof
|
US6299875B1
(en)
|
1998-06-04 |
2001-10-09 |
Panacea Pharmaceuticals, Llc |
Methods to block IGE binding to cell surface receptors of mast cells
|
GB9820014D0
(en)
|
1998-09-14 |
1998-11-04 |
Cancer Res Campaign Tech |
Receptor antagonists and uses thereof
|
US7083950B2
(en)
*
|
1998-09-25 |
2006-08-01 |
Regeneron Pharmaceuticals, Inc. |
High affinity fusion proteins and therapeutic and diagnostic methods for use
|
DE19848026A1
(de)
|
1998-10-17 |
2000-04-20 |
Bayer Ag |
Verfahren zur Herstellung von Bis(4-hydroxyaryl)alkanen
|
IL127127A0
(en)
|
1998-11-18 |
1999-09-22 |
Peptor Ltd |
Small functional units of antibody heavy chain variable regions
|
US7553487B2
(en)
|
1998-12-14 |
2009-06-30 |
Genetics Institute, Llc |
Method and compositions for treating asthma
|
ES2277460T3
(es)
|
1998-12-14 |
2007-07-01 |
Genetics Institute, Llc |
Cadena del receptor de la citoquina.
|
US6468528B1
(en)
|
1999-02-01 |
2002-10-22 |
Amgen Canada Inc. |
Materials and methods to inhibit Hodgkin and Reed Sternberg cell growth
|
AU1599301A
(en)
|
1999-11-11 |
2001-06-06 |
Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The |
Modulating IL-13 activity using mutated IL-13 molecules that are antagonists or agonists of IL-13
|
US20100041039A1
(en)
|
2000-01-15 |
2010-02-18 |
Synageva Biopharma Corp. |
Analysis of nucleic acid obtained from nucleated red blood cells
|
US6761667B1
(en)
|
2000-02-02 |
2004-07-13 |
Icon Ip, Inc. |
Hiking exercise apparatus
|
CN101670105B
(zh)
|
2000-02-24 |
2014-08-06 |
华盛顿大学 |
螯合淀粉样蛋白β肽的人源化抗体
|
AU3607301A
(en)
|
2000-03-03 |
2001-09-12 |
Kyowa Hakko Kogyo Kk |
Gene recombinant antibody and its fragment
|
CN1323812A
(zh)
|
2000-05-16 |
2001-11-28 |
上海博德基因开发有限公司 |
一种新的多肽——人白细胞介素-13(il-13)受体11和编码这种多肽的多核苷酸
|
AU1091802A
(en)
|
2000-10-20 |
2002-04-29 |
Chugai Pharmaceutical Co Ltd |
Degraded agonist antibody
|
DK1333850T3
(da)
|
2000-10-20 |
2008-12-01 |
Genetics Inst |
Anvendelse af IL-13-inhibitorer til behandling af tumorer
|
US7919467B2
(en)
*
|
2000-12-04 |
2011-04-05 |
Immunotope, Inc. |
Cytotoxic T-lymphocyte-inducing immunogens for prevention, treatment, and diagnosis of cancer
|
WO2002051870A2
(en)
|
2000-12-22 |
2002-07-04 |
GRAD, Carole Legal Representative of KAPLAN, Howard |
Phage display libraries of human vh fragments
|
JP2005518336A
(ja)
*
|
2001-06-26 |
2005-06-23 |
イムクローン システムズ インコーポレイティド |
Vegf受容体に結合する二重特異性抗体
|
WO2004081026A2
(en)
|
2003-06-30 |
2004-09-23 |
Domantis Limited |
Polypeptides
|
PT1449850E
(pt)
|
2001-08-31 |
2011-02-02 |
Kyowa Hakko Kirin Co Ltd |
Anticorpos humanos enxertados em rdc¿s e fragmentos desses anticorpos
|
US6908963B2
(en)
|
2001-10-09 |
2005-06-21 |
Nektar Therapeutics Al, Corporation |
Thioester polymer derivatives and method of modifying the N-terminus of a polypeptide therewith
|
JP2005289809A
(ja)
|
2001-10-24 |
2005-10-20 |
Vlaams Interuniversitair Inst Voor Biotechnologie Vzw (Vib Vzw) |
突然変異重鎖抗体
|
EP1578912A4
(en)
|
2001-10-26 |
2007-12-26 |
Centocor Inc |
IL-13 MUTEIN PROTEINS, ANTIBODIES, COMPOSITIONS, METHODS AND USES
|
US20030235555A1
(en)
|
2002-04-05 |
2003-12-25 |
David Shealey |
Asthma-related anti-IL-13 immunoglobulin derived proteins, compositions, methods and uses
|
CA2466492A1
(en)
|
2001-11-07 |
2003-05-15 |
Cytos Biotechnology Ag |
Antigen arrays presenting il-5, il-13 or eotaxin for treatment of allergic eosinophilic diseases
|
JP4460302B2
(ja)
|
2002-02-05 |
2010-05-12 |
ジェネンテック インコーポレイテッド |
タンパク質精製法
|
DK1501369T3
(en)
|
2002-04-26 |
2015-09-28 |
Genentech Inc |
Non-affinity purification of proteins
|
US7666411B2
(en)
|
2002-06-14 |
2010-02-23 |
The United States Of America As Represented By The Department Of Health And Human Services |
Methods of treating and preventing colitis involving IL-13 and NK-T cells
|
JP2006501249A
(ja)
|
2002-08-30 |
2006-01-12 |
グラクソ グループ リミテッド |
ワクチン
|
US20060147417A1
(en)
|
2002-08-30 |
2006-07-06 |
Claire Ashman |
Immunogenic composition comprising an il-13 element and t cell epitopes, and its therapeutic use
|
DE10303664A1
(de)
*
|
2003-01-23 |
2004-08-12 |
Nemod Immuntherapie Ag |
Erkennungsmoleküle zur Behandlung und Detektion von Tumoren
|
US7575747B2
(en)
|
2003-02-10 |
2009-08-18 |
Applied Molecular Evolution |
Aβ binding molecules
|
US7157276B2
(en)
|
2003-06-20 |
2007-01-02 |
Biogen Idec Inc. |
Use of depth filtration in series with continuous centrifugation to clarify mammalian cell cultures
|
GB0407315D0
(en)
|
2003-07-15 |
2004-05-05 |
Cambridge Antibody Tech |
Human antibody molecules
|
CA2532722C
(en)
|
2003-07-17 |
2016-10-04 |
Pacific Edge Biotechnology, Ltd. |
Cystatin sn (cst1) and other markers for detection of gastric cancer
|
ES2533084T3
(es)
|
2003-12-23 |
2015-04-07 |
Genentech, Inc. |
Tratamiento del cáncer con anticuerpos monoclonales anti-IL 13 novedosos
|
HUE026132T2
(en)
*
|
2004-01-07 |
2016-05-30 |
Novartis Vaccines & Diagnostics Inc |
M-CSF-specific monoclonal antibody and its uses
|
WO2005071410A1
(en)
*
|
2004-01-13 |
2005-08-04 |
Tanox, Inc. |
Detecting and quantifying host cell proteins in recombinant protein products
|
CN1965082A
(zh)
*
|
2004-02-06 |
2007-05-16 |
尼莫克斯股份有限公司 |
人源化抗体
|
US20070037966A1
(en)
|
2004-05-04 |
2007-02-15 |
Novo Nordisk A/S |
Hydrophobic interaction chromatography purification of factor VII polypeptides
|
US20070048785A1
(en)
|
2004-06-09 |
2007-03-01 |
Lin Laura L |
Anti-IL-13 antibodies and complexes
|
AR049390A1
(es)
|
2004-06-09 |
2006-07-26 |
Wyeth Corp |
Anticuerpos contra la interleuquina-13 humana y usos de los mismos
|
US7501121B2
(en)
|
2004-06-17 |
2009-03-10 |
Wyeth |
IL-13 binding agents
|
TWI307630B
(en)
|
2004-07-01 |
2009-03-21 |
Glaxo Group Ltd |
Immunoglobulins
|
PL1791565T3
(pl)
|
2004-09-23 |
2016-10-31 |
|
Modyfikowane cysteiną przeciwciała i koniugaty
|
NZ554520A
(en)
*
|
2004-10-22 |
2010-03-26 |
Amgen Inc |
Methods for refolding of recombinant antibodies
|
HUE049797T2
(hu)
|
2005-03-11 |
2020-10-28 |
Wyeth Llc |
Gyenge megoszlási kromatográfiás eljárás
|
WO2006110277A1
(en)
|
2005-04-11 |
2006-10-19 |
Medarex, Inc. |
Protein purification using hcic amd ion exchange chromatography
|
WO2007036745A2
(en)
|
2005-09-30 |
2007-04-05 |
Medimmune Limited |
Interleukin-13 antibody composition
|
EP2532679B1
(en)
|
2005-10-21 |
2017-04-12 |
Novartis AG |
Human antibodies against il13 and therapeutic uses
|
KR20140087058A
(ko)
|
2005-11-30 |
2014-07-08 |
애브비 인코포레이티드 |
아밀로이드 베타 단백질에 대한 모노클로날 항체 및 이의 용도
|
JO2824B1
(en)
|
2005-12-12 |
2014-09-15 |
اف . هوفمان لاروش ايه جي |
Antibody glycosylate in the changing region
|
BRPI0619748B8
(pt)
|
2005-12-12 |
2021-05-25 |
Ac Immune Sa |
anticorpo monoclonal, polinucleotídeo, composição, mistura, uso de um anticorpo monoclonal ou uma parte funcional do mesmo, método para preparar uma composição farmacêutica, linhagem celular de hibridoma isolado, método de diagnóstico de uma doença ou condição associada a amilóide em um paciente, método para diagnosticar uma predisposição para uma doença ou condição, método para monitorar doença residual mínima, método para prever a responsividade de um paciente e kits de teste
|
AU2006332216A1
(en)
*
|
2005-12-30 |
2007-07-12 |
Merck Patent Gmbh |
Anti-IL-6 antibodies preventing the binding of IL-6 complexed with IL-6Ralpha to gp130
|
US7563875B2
(en)
*
|
2006-03-20 |
2009-07-21 |
The United States of America as represented by the Sercretary of the Army |
Recombinant chimeric human anti-botulinum antibodies
|
NZ611859A
(en)
|
2006-04-05 |
2014-12-24 |
Abbvie Biotechnology Ltd |
Antibody purification
|
CN101472947A
(zh)
*
|
2006-04-21 |
2009-07-01 |
惠氏公司 |
用于高通量筛选细胞系的方法
|
CA2657681C
(en)
|
2006-07-14 |
2019-03-19 |
Ac Immune S.A. |
Humanized antibodies against beta amyloid protein
|
CL2007002567A1
(es)
*
|
2006-09-08 |
2008-02-01 |
Amgen Inc |
Proteinas aisladas de enlace a activina a humana.
|
ES2451266T3
(es)
*
|
2006-09-21 |
2014-03-26 |
Dsm Ip Assets B.V. |
Fosfolipasas, ácidos nucleicos que las codifican, y métodos para obtenerlas y usarlas
|
EP2074145B1
(en)
|
2006-10-02 |
2017-08-16 |
AC Immune S.A. |
Humanized antibody against amyloid beta
|
KR101551984B1
(ko)
|
2006-10-04 |
2015-09-09 |
제넨테크, 인크. |
Vegf용 elisa
|
US20080299585A1
(en)
*
|
2006-12-18 |
2008-12-04 |
Paul Truex |
METHODS FOR DETECTION AND MEASUREMENT OF SECRETORY PHOSPHOLIPASE A2 LEVELS (sPLA2) IN BIOLOGICAL FLUIDS
|
US8383350B1
(en)
|
2006-12-20 |
2013-02-26 |
Merck Sharp & Dohme Corp. |
Assay for detection of IL-10 antibodies
|
EP2114451A2
(en)
|
2007-01-09 |
2009-11-11 |
Wyeth a Corporation of the State of Delaware |
Anti-il-13 antibody formulations and uses thereof
|
WO2008140455A1
(en)
|
2007-05-15 |
2008-11-20 |
Tanox, Inc. |
Treatment of radiation and chemo-therapy induced fibrosis using novel anti-il 13 monoclonal antibodies
|
AR066987A1
(es)
|
2007-06-12 |
2009-09-23 |
Ac Immune Sa |
Anticuerpo monoclonal contra proteina beta-amiloide
|
JP2010530744A
(ja)
|
2007-06-12 |
2010-09-16 |
エーシー イミューン ソシエテ アノニム |
アミロイドβに対するヒト化抗体
|
US9433922B2
(en)
|
2007-08-14 |
2016-09-06 |
Emd Millipore Corporation |
Media for membrane ion exchange chromatography based on polymeric primary amines, sorption device containing that media, and chromatography scheme and purification method using the same
|
SG178809A1
(en)
|
2007-10-05 |
2012-03-29 |
Genentech Inc |
Use of anti-amyloid beta antibody in ocular diseases
|
PT2238166E
(pt)
|
2007-10-05 |
2014-02-11 |
Genentech Inc |
Utilização do anticorpo anti-amilóide beta em doenças oculares
|
NZ601858A
(en)
|
2007-10-05 |
2014-03-28 |
Genentech Inc |
Methods and compositions for diagnosis and treatment of amyloidosis
|
CA2718120A1
(en)
|
2008-03-31 |
2009-10-08 |
Genentech, Inc. |
Compositions and methods for treating and diagnosing asthma
|
US8344115B2
(en)
|
2008-04-21 |
2013-01-01 |
Chan-Sui Pang, legal representative |
Immunoassay for specific determination of S-adenosylmethionine and analogs thereof in biological samples
|
NZ623706A
(en)
|
2008-05-05 |
2015-12-24 |
Novimmune Sa |
Anti-il-17a/il-17f cross-reactive antibodies and methods of use thereof
|
KR101667319B1
(ko)
*
|
2008-08-05 |
2016-10-18 |
도레이 카부시키가이샤 |
암의 치료 및 예방용 의약 조성물
|
US8790642B2
(en)
|
2008-08-29 |
2014-07-29 |
Genentech, Inc. |
Cross-reactive and bispecific anti-IL-17A/F antibodies
|
GB0818674D0
(en)
|
2008-10-10 |
2008-11-19 |
Univ Bath |
Materials and methods for resolving polyhydric species by electrophoresis
|
RU2514657C2
(ru)
|
2008-10-20 |
2014-04-27 |
Эббви Инк, |
Способ получения препарата антитела против il-18 или его антигенсвязывающей части (варианты)
|
SG10201702922VA
(en)
|
2008-10-20 |
2017-06-29 |
Abbvie Inc |
Isolation and purification of antibodies using protein a affinity chromatography
|
SG10201702951RA
(en)
|
2008-10-20 |
2017-06-29 |
Abbvie Inc |
Viral inactivation during purification of antibodies
|
EP2346898A2
(en)
|
2008-10-20 |
2011-07-27 |
Abbott Laboratories |
Antibodies that bind to il-12 and methods of purifying the same
|
CN101979404B
(zh)
*
|
2008-12-09 |
2015-01-14 |
厦门大学 |
H5亚型禽流感病毒保守中和表位模拟肽及其用途
|
FR2944448B1
(fr)
|
2008-12-23 |
2012-01-13 |
Adocia |
Composition pharmaceutique stable comprenant au moins un anticorps monodonal et au moins un polysacharide amphiphile comprenant des substituants derives d'alcools hydrofobes ou d'amines hydrophobes.
|
KR20190018041A
(ko)
|
2009-08-06 |
2019-02-20 |
제넨테크, 인크. |
단백질 정제 시의 바이러스 제거의 개선방법
|
EP2473531A4
(en)
*
|
2009-09-03 |
2013-05-01 |
Merck Sharp & Dohme |
ANTI-GITRANT ANTIBODIES
|
UA109884C2
(uk)
*
|
2009-10-16 |
2015-10-26 |
|
Поліпептид, що має активність ферменту фосфатидилінозитол-специфічної фосфоліпази с, нуклеїнова кислота, що його кодує, та спосіб його виробництва і застосування
|
CN104744560A
(zh)
|
2009-10-20 |
2015-07-01 |
Abbvie公司 |
使用蛋白a亲和色谱法分离和纯化抗-il-13抗体
|
SI2530091T1
(en)
*
|
2010-01-29 |
2018-06-29 |
Chugai Seiyaku Kabushiki Kaisha |
PROTITELO ANTI-DLL3
|
HUE045487T2
(hu)
*
|
2010-03-04 |
2019-12-30 |
Macrogenics Inc |
B7-H3-ra reaktív antitestek, immunológiailag aktív fragmenseik és alkalmazásaik
|
US8802091B2
(en)
*
|
2010-03-04 |
2014-08-12 |
Macrogenics, Inc. |
Antibodies reactive with B7-H3 and uses thereof
|
PT2569013T
(pt)
*
|
2010-05-14 |
2017-02-08 |
Univ Leland Stanford Junior |
Anticorpos monoclonais humanizados e quiméricos para cd47
|
CA2798778C
(en)
*
|
2010-05-17 |
2016-01-05 |
Livtech, Inc. |
Anti-human trop-2 antibody having anti-tumor activity in vivo
|
CN102905718A
(zh)
|
2010-05-25 |
2013-01-30 |
弗·哈夫曼-拉罗切有限公司 |
纯化多肽的方法
|
EP2591005A2
(en)
*
|
2010-07-06 |
2013-05-15 |
Aveo Pharmaceuticals, Inc. |
Anti-ron antibodies
|
JP6081356B2
(ja)
|
2010-07-30 |
2017-02-15 |
エーシー イミューン エス.エー. |
安全で機能的なヒト化抗βアミロイド抗体
|
AU2011312425A1
(en)
|
2010-09-29 |
2013-04-11 |
Genentech, Inc. |
Antibody compositions and methods of use
|
EP2646470B1
(en)
|
2010-11-30 |
2017-03-01 |
F. Hoffmann-La Roche AG |
Low affinity anti-transferrin receptor antibodies and their use to transfer therapeutic scfv across the blood brain barrier
|
US20120156194A1
(en)
|
2010-12-16 |
2012-06-21 |
Genentech, Inc. |
Diagnosis and treatments relating to th2 inhibition
|
MX338353B
(es)
*
|
2011-04-20 |
2016-04-13 |
Medimmune Llc |
Anticuerpos y otras moleculas que se unen a b7 - h1 y pd - 1.
|
CN104039826A
(zh)
|
2011-10-31 |
2014-09-10 |
弗·哈夫曼-拉罗切有限公司 |
抗体制剂
|
WO2013066707A1
(en)
|
2011-10-31 |
2013-05-10 |
Merck Sharp & Dohme Corp. |
Chromatography process for resolving heterogeneous antibody aggregates
|
MD20140108A2
(ro)
*
|
2012-02-29 |
2015-03-31 |
Gilead Biologics, Inc. |
Anticorpi împotriva metaloproteinazei 9 matriciale
|
US10091883B2
(en)
|
2013-07-10 |
2018-10-02 |
Gemalto Sa |
Dielectric filmless electronic module and method for manufacturing same
|
JP6546178B2
(ja)
|
2013-09-13 |
2019-07-17 |
ジェネンテック, インコーポレイテッド |
細胞株中の宿主細胞タンパク質及び組換えポリペプチド産物を検出及び定量化するための組成物並びに方法
|
JP7080219B2
(ja)
*
|
2016-08-30 |
2022-06-03 |
ゼンコア インコーポレイテッド |
共刺激受容体およびチェックポイント受容体に連結する二重特異性免疫調節抗体
|